Pterygium

Evidence-based assessment and management of fibrovascular conjunctival invasion of the cornea. Comprehensive guide covering UV pathogenesis, Tan and Johnston grading, Stocker's line, astigmatic effects, surgical options, and recurrence prevention for optometry practice.

Last updated: March 2026

PterygiumbodyCap &Stocker's lineLimbus

Nasal pterygium — intermediate grade — fibrovascular triangular tissue arising from the nasal bulbar conjunctiva, crossing the limbus with a fibrovascular body, cap zone, and Stocker's iron deposition line at the advancing head

Fleshypterygium (T3)Visualaxis

Advanced pterygium (T3 — fleshy) — thick, vascular, opaque fibrovascular mass encroaching on the cornea toward the visual axis; high risk of significant induced astigmatism and visual impairment

A pterygium (from the Greek pterygion, meaning wing) is a fibrovascular proliferation of subconjunctival tissue that grows across the limbus to invade the corneal surface. Unlike a pinguecula — which remains confined to the conjunctiva — a pterygium is characterised by the progressive destruction of Bowman's layer and superficial corneal stroma as the leading fibrovascular pannus advances centrally. This corneal invasion distinguishes pterygium as a potentially vision-threatening condition requiring active monitoring and, in selected cases, surgical intervention.

Pterygia are predominantly nasal (approximately 90% of cases), likely due to the limbal focusing effect of UV radiation described by Coroneo (1993), which concentrates UV light on the nasal limbal area via peripheral corneal optics. The condition may be unilateral or bilateral, with bilateral occurrence in up to 30–40% of cases in high UV-exposure populations.

Globally, pterygium prevalence ranges from 1% in temperate climates to over 22% in some tropical and subtropical populations. In Singapore, population-based studies (Tanjong Pagar Survey, Singapore Malay Eye Study, Singapore Indian Eye Study) report prevalence rates of 7–10% in adults, with significantly higher rates in outdoor workers and individuals with prolonged sun exposure. Singapore's equatorial location and extreme UV index make pterygium one of the most commonly encountered anterior segment conditions in local optometry practice.

Pterygium is a multifactorial condition, with ultraviolet radiation as the dominant and best-established etiological driver. The condition represents a complex interplay of environmental, genetic, cellular, and molecular factors.

Ultraviolet Radiation

UV-B radiation (290–320 nm) is the principal environmental cause. The "limbal focusing effect" (Coroneo hypothesis) explains the nasal predominance: peripheral corneal optics refract and concentrate oblique UV rays onto the nasal limbal zone at up to 20 times the ambient intensity. This creates a UV hotspot at the nasal limbus that selectively damages limbal stem cells, initiating pterygium formation. Epidemiological evidence consistently demonstrates a strong dose-response relationship between cumulative UV exposure and pterygium prevalence and severity.

Limbal Stem Cell Dysfunction

Current evidence supports the hypothesis that pterygium arises from a UV-induced mutation or dysfunction of limbal stem cells — the progenitors that maintain the corneal epithelial boundary. Altered limbal stem cells lose their regulatory function, allowing conjunctival epithelium and subepithelial fibrovascular tissue to breach Bowman's layer and invade the cornea. This is supported by the detection of conjunctival phenotype markers (MUC5AC, cytokeratin 19) in pterygium epithelium and by the expression of vimentin-positive altered basal epithelial cells at the advancing head.

Molecular and Cellular Mechanisms

  • p53 tumour suppressor gene mutation — UV-induced p53 mutations in pterygium epithelium prevent normal apoptosis of damaged cells, enabling proliferative and invasive behaviour
  • Growth factor upregulation — elevated VEGF, TGF-β, EGF, and FGF-2 promote angiogenesis, fibroblast proliferation, and extracellular matrix remodelling within the pterygium stroma
  • Matrix metalloproteinases (MMPs) — MMP-1, MMP-2, MMP-3, and MMP-9 are overexpressed, facilitating destruction of Bowman's layer and stromal collagen at the advancing pterygium head
  • Inflammatory mediators — IL-1, IL-6, IL-8, and TNF-α contribute to the chronic low-grade inflammatory microenvironment driving pterygium growth and recurrence

Other Contributing Factors

  • Chronic desiccation and wind/dust exposure — ocular surface dryness amplifies UV-induced damage and promotes inflammatory fibroblast activation
  • Genetic susceptibility — familial clustering and twin studies suggest a heritable component; specific HLA associations and gene polymorphisms (VEGF, MMP) have been reported in some populations
  • Human papillomavirus (HPV) — HPV DNA (particularly subtypes 6, 11, 16, 18) has been detected in pterygium tissue in some studies, though a causal role remains unproven and inconsistent across populations

Pterygium pathogenesis is best understood as a UV-initiated, stem cell–mediated fibrovascular proliferative process, with overlapping features of wound healing, neoplasia, and chronic inflammation.

Limbal stem cell damage and conjunctivalisation. The corneal epithelium is maintained by limbal stem cells (LSCs) located in the Palisades of Vogt at the corneoscleral junction. Repetitive UV-B irradiation generates reactive oxygen species (ROS) that cause strand breaks in LSC DNA, triggering p53-dependent and p53-independent apoptosis pathways. When p53 is mutated (as is common in pterygium), damaged LSCs survive and undergo transformation, losing their barrier function. Conjunctival fibroblasts and epithelium then migrate centrally, replacing corneal epithelium — a process termed "conjunctivalisation."

Bowman's layer dissolution. The advancing pterygium head is preceded by a zone of fibrovascular tissue that secretes MMPs — particularly MMP-1 (interstitial collagenase) and MMP-9 (gelatinase B) — which dissolve the collagen IV scaffold of Bowman's layer. This irreversible destruction explains why even successful pterygium excision leaves a permanent Bowman's layer defect and potential scarring at the excision site.

Angiogenesis and fibrovascular stroma. VEGF overexpression, driven by UV-induced HIF-1α activation, stimulates robust neovascularisation within the pterygium body. These feeder vessels supply the growing fibrovascular mass and confer the characteristic reddish appearance of active pterygia. Subepithelial fibroblasts produce disordered collagen (types I, III, and V) interspersed with elastotic fibres, forming the fleshy stroma of the mature lesion.

Corneal flattening and astigmatism induction. As the fibrovascular mass anchors to the corneal stroma, the mechanical pull of the pterygium along its axis flattens the corneal curvature in the axis of the pterygium and steepens the perpendicular axis, producing characteristic with-the-rule or against-the-rule astigmatism. The degree of induced astigmatism correlates with the length of corneal invasion and the bulk of the pterygium body.

Recurrence biology. Post-surgical recurrence is driven by residual fibrovascular stem cells in the episcleral tissue and Tenon's capsule. Residual VEGF, TGF-β, and inflammatory cytokine signalling stimulates renewed fibroblast migration and angiogenesis at the surgical site. This is the mechanistic basis for adjunctive use of antimetabolites (mitomycin C, 5-fluorouracil) and anti-VEGF agents in high-recurrence cases.

Multiple classification systems have been developed. The two most widely adopted are the Tan grading system (based on pterygium translucency and underlying episcleral vessel visibility) and the Johnston morphological classification (based on tissue texture). Both are clinically applicable and predict recurrence risk.

Tan Grading System (T1–T3)

Graded by translucency — visibility of underlying episcleral vessels through the pterygium body.

GradeDescriptionVessel VisibilityRecurrence Risk
T1 (Atrophic)Thin, translucent; episcleral vessels clearly visible through pterygium bodyClearly visibleLow (~5–10%)
T2 (Intermediate)Partially opaque; episcleral vessels partially obscuredPartially obscuredIntermediate (~15–20%)
T3 (Fleshy)Thick, opaque, vascular; episcleral vessels completely obscuredNot visibleHigh (~30–45% with autograft; higher with bare sclera)

Johnston Morphological Classification

  • Atrophic — thin, flat, with minimal vascularity; underlying sclera and episcleral vessels visible; low recurrence risk post-excision
  • Intermediate — moderately elevated; partially opaque; moderate vascularity
  • Fleshy (hypertrophic) — thick, elevated, highly vascular, opaque; highest recurrence risk; overlapping with T3 in Tan grading

Corneal Extent (Functional Grading)

  • Grade 1 — pterygium head within 2 mm of limbus on the cornea
  • Grade 2 — head extending 2–4 mm onto the cornea; may begin inducing astigmatism
  • Grade 3 — head reaching the pupil margin; significant astigmatism likely
  • Grade 4 — head crossing the pupil and approaching or covering the visual axis; vision directly threatened

Primary vs Recurrent

  • Primary pterygium — first presentation; has not been surgically excised
  • Recurrent pterygium — regrowth following previous excision; typically more aggressive, vascular, and difficult to manage than primary disease; higher recurrence rates with each subsequent excision
  • Cumulative UV exposure — the strongest modifiable risk factor; a clear dose-response relationship exists; UV-B in particular is most damaging. Singapore's equatorial UV index (typically 10–14, classified as Extreme) drives high local pterygium prevalence
  • Geographic latitude — within 37° of the equator ("pterygium belt"); prevalence drops sharply at higher latitudes. Singapore, at 1.3°N, lies squarely within the high-risk zone
  • Outdoor occupation and recreational exposure — farmers, fishermen, military personnel, construction workers, surfers; a dose-response relationship with years of outdoor work has been demonstrated in multiple Singapore cohort studies
  • Male sex — consistently higher prevalence in males in most epidemiological studies; largely attributable to greater occupational outdoor UV exposure rather than a biological sex difference per se
  • Advancing age — prevalence increases with age due to cumulative UV exposure; peak prevalence in the fourth to sixth decades; rare below age 20
  • Dry and dusty environments — chronic ocular surface desiccation and particulate exposure promote limbal microtrauma and inflammatory activation
  • Absence of UV-protective eyewear — not wearing sunglasses or wide-brimmed hats is an independent modifiable risk factor; UV400 wrap-around eyewear is protective
  • Ethnicity — some studies report higher rates in Asian and African populations compared to European populations within the same geographic region, suggesting possible genetic susceptibility differences
  • Genetic susceptibility — familial occurrence is documented; VEGF promoter polymorphisms and HLA associations have been reported in selected populations
  • Previous pterygium excision — prior excision is the strongest risk factor for recurrent pterygium; recurrent disease is more aggressive and has higher subsequent recurrence rates
  • Smoking — some evidence suggests ROS from cigarette smoke compounds UV-induced limbal damage

Structural Features

  • Triangular fibrovascular tissue — apex (head) pointing centrally onto the cornea; base at or near the medial or lateral canthus. The nasal location is by far the most common; temporal pterygia occur in approximately 10% of cases
  • Three anatomical zones:
    • Head — the advancing corneal portion; grey-white or transparent; at its leading edge lies the cap zone
    • Neck — the limbal portion where pterygium crosses from conjunctiva to cornea
    • Body — the conjunctival portion; contains the feeder vessels and fibrovascular stroma
  • Cap zone — a greyish, relatively avascular zone immediately anterior to the pterygium head on the cornea; represents degenerating Bowman's layer tissue ahead of the advancing front
  • Stocker's line — a brown iron deposition line (haemosiderin) in the corneal epithelium at the apex of a slowly advancing or stationary pterygium head; seen in approximately 30% of cases; indicates a more quiescent lesion. When absent, it may suggest a more active or rapidly advancing pterygium
  • Fuchs' flecks / islands — greyish-white opaque spots at the leading edge of some pterygia; represent aggregates of degenerate tissue at the advancing head

Vascularity Signs

  • Active, fleshy (T3) pterygia — prominent dilated feeder vessels running along the length of the body; intense red appearance; may show episodic inflammatory flares
  • Atrophic (T1) pterygia — thin, translucent; episcleral vessels clearly visible through the body; less vascular
  • Conjunctival injection — localised or diffuse redness overlying the pterygium during active growth or inflammatory episodes

Corneal and Refractive Signs

  • Induced corneal astigmatism — mechanical flattening in the axis of the pterygium produces regular or irregular astigmatism; detectable on corneal topography before visible corneal distortion on slit-lamp
  • Corneal distortion at the limbus — subtle distortion of the corneal contour visible on slit-lamp at the site where pterygium crosses the limbus
  • Bowman's layer destruction — visible on AS-OCT as disruption of the bright sub-epithelial line beneath the pterygium head

Motility and Diplopia Signs

  • Restriction of ocular motility — in large or recurrent pterygia, fibrotic adhesion to the sclera and conjunctiva may restrict movement in the direction of the pterygium (typically medial gaze for nasal pterygium)
  • Diplopia — rare; occurs with very large or adherent pterygia causing significant motility restriction
  • Asymptomatic (common in early grades) — small atrophic pterygia may be entirely symptom-free and discovered incidentally on routine examination
  • Cosmetic concern — the visible reddish triangular mass on the white of the eye is a frequent presenting complaint, particularly in younger patients
  • Ocular surface irritation — foreign body sensation, grittiness, burning, and mild discomfort from chronic ocular surface irregularity; exacerbated by dry or dusty environments and air conditioning — all highly relevant to Singapore's indoor climate
  • Redness — localised injection over the pterygium body, particularly during inflammatory flares or periods of increased UV or environmental exposure
  • Epiphora (tearing) — reflex tearing from ocular surface irritation
  • Blurred or distorted vision — progressive visual impairment from induced irregular astigmatism; becomes clinically significant as the pterygium head encroaches beyond 2–3 mm onto the cornea. Spectacle or contact lens correction may partially compensate but cannot correct irregular astigmatism
  • Visual axis obstruction — in advanced (Grade 3–4) pterygia reaching or crossing the pupil margin; direct mechanical obstruction of the visual axis causes significant vision loss
  • Contact lens intolerance — the elevated, irregular tissue makes both soft and rigid lens fitting problematic; induced astigmatism may render previously successful lens wearers intolerant
  • Restricted ocular motility — in large or adherent pterygia; patient may complain of difficulty looking toward the pterygium or, rarely, of diplopia
  • Progressive corneal invasion and visual axis encroachment — the most serious natural history complication; once the pterygium head crosses the pupil margin (Grade 3–4), vision is directly threatened by mechanical axis obstruction and dense irregular astigmatism
  • Irregular corneal astigmatism — the primary cause of visual impairment in pterygium; induced by mechanical traction on the corneal stroma; may not be fully correctable with spectacles or standard soft contact lenses; hard contact lenses or scleral lenses may improve acuity but do not address the underlying progression
  • Permanent Bowman's layer scarring — corneal haze and subepithelial scarring at the pterygium head site persists even after successful excision; may leave permanent irregular astigmatism and suboptimal best-corrected visual acuity
  • Ocular motility restriction and diplopia — fibrous adhesion of the pterygium to the scleral and episcleral tissue in advanced or recurrent cases; may require strabismus surgery in addition to pterygium excision
  • Dry eye exacerbation — the elevated pterygium mass disrupts the precorneal tear film, worsening pre-existing dry eye and amplifying ocular surface symptoms
  • Contact lens fitting failure — progressive irregular astigmatism and conjunctival tissue distortion make contact lens wear increasingly difficult
  • Recurrence after excision — the most common surgical complication; recurrence rates vary widely (5–80%) depending on surgical technique; recurrent pterygia are typically more vascular, fibrous, and invasive than the primary lesion, with increasing risk with each subsequent excision
  • Post-surgical complications — dellen formation at graft edges, conjunctival graft displacement or necrosis, scleral or corneal melt (particularly with overuse of MMC), pyogenic granuloma formation, symblepharon (conjunctival adhesion), and infectious keratoscleritis
  • Interference with LASIK / refractive surgery candidacy — induced irregular astigmatism and corneal distortion compromise corneal topography assessment and contraindicate keratorefractive surgery; pterygium must be excised and the cornea allowed to stabilise (minimum 3–6 months) before any refractive procedure

Pterygium is primarily a localised ocular surface condition without direct systemic disease associations of the same nature as scleritis or episcleritis. However, several systemic and epidemiological relationships are clinically relevant.

UV Exposure as a Shared Systemic Risk Marker

Pterygium is a robust marker of high cumulative UV exposure. Patients presenting with pterygium — particularly at a young age or with bilateral, aggressive disease — should be counselled on their elevated risk of other UV-related conditions: skin cancers (basal cell carcinoma, squamous cell carcinoma, melanoma), actinic keratosis, cataract (particularly cortical subtype), and age-related macular degeneration (AMD). Sun protection behaviour counselling extends beyond the eye to total UV risk management.

Dry Eye Disease

Pterygium and dry eye disease (DED) share a bidirectional relationship. Pterygium-induced tear film disruption worsens DED, while the inflammatory milieu of DED promotes pterygium growth. Sjögren's syndrome, thyroid eye disease, and other systemic conditions causing severe DED can predispose to more symptomatic pterygium and may increase surgical complication risk by compromising post-operative ocular surface healing.

Xeroderma Pigmentosum

Patients with xeroderma pigmentosum (XP) — a rare autosomal recessive DNA nucleotide excision repair disorder — develop pterygia, pingueculae, and ocular surface squamous neoplasia at accelerated rates and at a young age, due to impaired UV-induced DNA repair. This extreme phenotype illuminates the central role of UV DNA damage in pterygium biology.

Atopy and Allergy

Some evidence suggests a higher rate of atopic conditions (allergic conjunctivitis, atopic dermatitis) in pterygium patients, possibly mediated by shared inflammatory pathways (IgE-mediated mast cell activation, eosinophil infiltration). Active allergic conjunctivitis may exacerbate pterygium-related symptoms and inflammatory activity.

Clinical note: Pterygium does not require systemic investigation in the majority of cases. The key systemic consideration is UV photoprotection counselling encompassing total UV exposure (ocular and cutaneous) and referring the patient to a dermatologist if suspicious skin lesions are noted.

Pterygium is a clinical diagnosis based on characteristic slit-lamp findings. Ancillary investigations are important for surgical planning, monitoring progression, and excluding atypical or malignant mimics.

Slit-Lamp Biomicroscopy

  • Diffuse illumination — identify the triangular morphology, nasal or temporal location, and overall extent (body, neck, head)
  • Direct focal illumination — assess the head position relative to the limbus and corneal centre; identify the cap zone, Stocker's line, and Fuchs' flecks; characterise vessel pattern (feeder vessels in body)
  • Sclerotic scatter — map corneal clarity and detect subtle corneal involvement or early Bowman's disruption anterior to the head
  • Broad tangential illumination — assess pterygium elevation and thickness; helps grade T1/T2/T3
  • Fluorescein staining with cobalt-blue filter — reveals associated corneal epithelial staining, tear film TBUT disruption, and any adjacent dellen

Ancillary Investigations

  • Corneal topography (Placido disc / Scheimpflug) — essential for quantifying induced astigmatism; documents irregular astigmatism and central corneal distortion; critical for surgical planning and monitoring progression; also necessary to establish a baseline for LASIK candidacy assessment after excision
  • Corneal tomography (Pentacam / Orbscan) — characterises both anterior and posterior corneal surface changes; more sensitive than topography alone for detecting early induced ectatic changes
  • Anterior segment OCT (AS-OCT) — quantifies pterygium thickness and extent of Bowman's layer disruption; monitors head progression with high precision; assists in surgical planning by mapping the exact corneal invasion depth
  • Anterior segment photography — mandatory baseline documentation; at minimum, measure the distance of the pterygium head from the centre of the cornea (limbus-to-head distance) at each visit using slit-lamp reticule or digital measurement tools
  • Refraction and best-corrected visual acuity (BCVA) — serial refractions allow objective monitoring of induced astigmatism progression; a change in refraction between visits can precede visible topographic change

Atypical Features Warranting Referral

  • Rapid growth over weeks to months
  • Pigmentation (brown, black, or grey) suggesting melanocytic activity
  • Papillomatous, gelatinous, or haemorrhagic surface texture
  • Prominent irregular feeder or sentinel vessels
  • Unusual location (superior, inferior, or not aligned with the interpalpebral axis)
  • Ulceration of the overlying epithelium
  • Recurrence after previous excision with atypical features

Any of the above should prompt urgent ophthalmological referral for excision biopsy to exclude conjunctival intraepithelial neoplasia (CIN) or squamous cell carcinoma.

Singapore Optometry Scope Note: Optometrists in Singapore may independently manage small, stable, asymptomatic pterygia with lubricants, UV protection counselling, and serial monitoring. Optometrists cannot prescribe topical NSAIDs or corticosteroids. Patients with progressive pterygium, significant induced astigmatism, visual symptoms, or inflammation should be co-managed with or referred to an ophthalmologist. Surgical decisions and post-operative care are managed by ophthalmology. Posterior segment assessment must use approved non-dilating diagnostic equipment (e.g., non-contact widefield fundus imaging or OCT); dilated fundus examination is not within the optometry scope of practice in Singapore.

Conservative Management (Stable, Asymptomatic Pterygium)

  • Observation and photodocumentation — for small (Grade 1), atrophic (T1), stable pterygia that are not approaching the visual axis; 6–12 monthly review with serial anterior segment photography and corneal topography
  • UV-protective eyewear — wrap-around UV400 sunglasses and broad-brimmed hats; the most critical preventive and progression-retarding measure; particularly important in Singapore given the year-round extreme UV index
  • Preservative-free artificial tears — sodium hyaluronate (0.1–0.3%) or carboxymethylcellulose (0.5–1%) for symptomatic dry eye and foreign body sensation; reduce ocular surface inflammation and irritation
  • Ocular surface optimisation — manage concurrent dry eye disease; advise on blink hygiene during screen use; humidifiers in air-conditioned workplaces
  • Referral triggers for conservative management — any documented growth on serial photography or topography; induced astigmatism >1.00 D; head encroaching within 2–3 mm of the corneal centre; worsening vision; or patient request for excision

Pharmacological Management (Prescribed by Ophthalmologist or GP)

The following medications require a prescription. Optometrists in Singapore cannot prescribe these agents; refer patients with active inflammation or significant symptoms to an ophthalmologist.

  • Topical NSAIDs — ketorolac tromethamine 0.5% or diclofenac 0.1% QID during acute inflammatory flares; reduces prostaglandin-mediated episodic hyperaemia; does not arrest pterygium growth
  • Topical corticosteroids (short course) — fluorometholone 0.1% or prednisolone acetate 0.5–1% QID for 1–2 weeks for active inflammation; IOP must be monitored; not recommended for prolonged use and does not alter pterygium growth
  • Anti-VEGF agents — subconjunctival bevacizumab (Avastin) has been investigated as a non-surgical adjunct to reduce pterygium vascularity and growth; current evidence shows temporary reduction in vascularity but limited effect on long-term growth or surgical recurrence rate; not standard of care

Surgical Management

Indications for surgery:

  • Progressive pterygium with documented growth on serial topography or photography
  • Significant induced astigmatism (>1.00–1.50 D) affecting visual acuity or spectacle tolerance
  • Head extending within 2–3 mm of the corneal centre or threatening the visual axis (Grade 2–3)
  • Ocular motility restriction causing diplopia
  • Cosmetically unacceptable appearance with documented patient distress
  • Pre-LASIK or pre-cataract surgery corneal regularisation
  • Atypical morphology requiring excision biopsy

Surgical techniques (by recurrence risk, lowest to highest):

TechniqueDescriptionRecurrence Rate
Conjunctival autograft (CAG) ± fibrin glueGold standard; autologous superior bulbar conjunctiva harvested and transposed to the excision site; fibrin glue fixation reduces operative time and is as effective as sutures5–15% (primary); 10–25% (recurrent)
Amniotic membrane transplantation (AMT)Used when insufficient superior conjunctiva is available (e.g., glaucoma filtration surgery planned, prior conjunctival surgery); fresh or cryopreserved amnion; comparable to CAG in many series10–25%
CAG + intraoperative mitomycin C (MMC)Adjunctive antimetabolite applied to bare sclera for 1–5 minutes before grafting; significantly reduces recurrence in high-risk cases (T3, recurrent pterygium); risk of scleral or corneal melt with excessive dose or exposure3–8% (select series)
Bare sclera excisionHistorical technique; simple excision without conjunctival replacement; not recommended due to very high recurrence (30–80%) and risk of symblepharon30–80% (not recommended)

The prognosis of pterygium is generally good with appropriate monitoring and timely surgical intervention, but strongly depends on pterygium grade, surgical technique, and patient compliance with UV protective measures post-operatively.

  • Vision preservation — the vast majority of patients retain good visual acuity if the pterygium is identified and surgically excised before reaching the visual axis. Vision loss from direct axis obstruction is largely preventable with early referral
  • Astigmatism outcome — induced astigmatism partially or fully resolves after excision; the degree of recovery depends on the extent of Bowman's layer destruction and the duration of corneal involvement. Significant irregular astigmatism and corneal scarring from advanced pterygium may persist despite successful excision
  • Recurrence risk — the dominant prognostic variable post-operatively. Conjunctival autograft reduces recurrence to 5–15% compared to 30–80% with bare sclera excision. Recurrent pterygia carry higher recurrence risk with each subsequent surgery and are more difficult to manage. Younger age, T3 morphology, and nasal location predict higher recurrence
  • Photoprotection compliance — the single most modifiable post-operative prognostic factor; consistent UV400 sunglasses wear significantly reduces recurrence risk and contralateral eye progression. Patient education is fundamental
  • Corneal scarring — permanent Bowman's layer scarring at the excision site is universal after significant corneal invasion; the severity ranges from mild haze to dense leucoma affecting BCVA. Excimer laser phototherapeutic keratectomy (PTK) may improve corneal clarity in selected cases post-excision
  • Refractive surgery candidacy — after pterygium excision, corneal topography should be repeated at a minimum of 3–6 months (some surgeons advocate 6–12 months) to confirm stabilisation of the corneal surface before any keratorefractive procedure is planned
  • Bilateral progression — patients with a unilateral pterygium should be monitored for contralateral pterygium or pinguecula progression, as the same UV exposure risk applies to both eyes
ConditionKey Distinguishing Features
PingueculaYellowish-white conjunctival deposit in the interpalpebral zone; does NOT cross the limbus onto the cornea; no Stocker's line or cap zone; no induced astigmatism; benign, non-progressive in most cases
Conjunctival intraepithelial neoplasia (CIN)Gelatinous, vascularised, or leukoplakic lesion at the limbus; may resemble early pterygium but typically has irregular surface texture, abnormal feeder vessels, or pigmentation; biopsy required for definitive diagnosis; can coexist with pterygium (requires histopathological exclusion in atypical excision specimens)
Conjunctival squamous cell carcinoma (SCC)Rapidly growing, papillomatous, nodular, or ulcerated conjunctival mass; prominent irregular vessels; may invade the cornea and sclera; urgent biopsy mandatory; any pterygium-like lesion with atypical rapid growth warrants exclusion of SCC
PseudopterygiumConjunctival fold adherent to the cornea following a localised inflammatory or traumatic insult (chemical burn, Stevens-Johnson syndrome, chronic ulcer, thermal injury); the distinguishing test: a probe or spatula can be passed beneath a pseudopterygium but NOT beneath a true pterygium (which is firmly adherent to Bowman's layer at its head)
Limbal dermoidSolid, white-yellow congenital choristoma at the inferotemporal limbus; present from birth; contains ectopic tissue (hair, sebaceous glands, adipose); does not grow aggressively; associated with Goldenhar syndrome; no UV aetiology or feeder vessels of pterygium type
Pannus (corneal vascularisation)Superficial fibrovascular tissue growing onto the peripheral cornea from all directions; associated with chronic contact lens hypoxia, trachoma, rosacea keratitis, or superior limbic keratoconjunctivitis; lacks the triangular nasal/temporal morphology of pterygium
Salzmann's nodular degenerationGrey-white elevated nodule(s) on the mid-peripheral cornea; typically superior; subepithelial fibrous tissue; not fibrovascular; not interpalpebral; associated with prior keratitis (phlyctenulosis, trachoma); no feeder vessels
Terrien's marginal degenerationBilateral, progressive peripheral corneal thinning; superior location; separated from limbus by clear zone; lipid deposition at the leading edge; no fibrovascular invasion of the cornea; thinning without perforation in most cases
  • Measure the head at every visit. Document the distance from the pterygium head to the corneal centre using the slit-lamp reticule or AS-OCT at each examination. A change of ≥0.5 mm per year is significant and warrants timely ophthalmological referral.
  • Corneal topography beats clinical estimation. Induced astigmatism begins before the pterygium head is visibly distorting the cornea. Topography detects this earlier than subjective refraction, enabling more timely surgical referral and reducing the risk of irreversible Bowman's layer scarring.
  • Pseudopterygium probe test. When uncertain whether a limbal lesion is a true pterygium or pseudopterygium, attempt to pass a blunt probe or spatula under the lesion head. If it slides freely, the diagnosis is pseudopterygium; if firmly adherent, it is a true pterygium.
  • Stocker's line indicates slow growth. The presence of a brown iron line at the pterygium head is a reassuring sign of a relatively quiescent lesion; its absence — particularly in a young patient — suggests active growth warranting more frequent monitoring.
  • Refer before the visual axis is threatened. The optimal window for surgical referral is when the head is at 2–3 mm from the corneal centre: early enough to avoid significant Bowman's scarring, late enough to avoid operating on a lesion that may not progress. Waiting until the visual axis is covered risks permanent corneal scarring.
  • UV protection counselling is the most important non-surgical intervention. Both for preventing progression in primary pterygium and reducing recurrence post-operatively. UV400 wrap-around sunglasses reduce oblique UV exposure most effectively — standard flat-frame glasses are less protective due to peripheral UV entry.
  • Singapore context: watch the young outdoor worker. Pterygium in a patient under 40 in Singapore is not rare given extreme UV exposure. Younger patients tend to have more aggressive pterygia with higher recurrence rates. Early monitoring and UV protection advice should begin at the first presentation.
  • Post-excision topography must stabilise before LASIK. Advise patients seeking refractive surgery after pterygium excision that corneal topography must be documented as stable for at least 3–6 months post-operatively before keratorefractive surgery can be considered. Residual irregular astigmatism post-excision may preclude or modify LASIK candidacy.
  1. Coroneo MT. Pterygium as an indicator of ultraviolet insolation: a hypothesis. Br J Ophthalmol. 1993;77(11):734–9.
  2. Wong TY, Foster PJ, Johnson GJ, Seah SK, Tan DT. The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar Survey. Am J Ophthalmol. 2001;131(2):176–83.
  3. Cajucom-Uy H, Tong L, Wong TY, Tay WT, Saw SM. The prevalence of and risk factors for pterygium in an urban Malay population: the Singapore Malay Eye Study (SiMES). Br J Ophthalmol. 2010;94(8):977–81.
  4. Tan CS, Lim TH, Koh WP, et al. Epidemiology of pterygium on a tropical island in the Riau Archipelago. Eye (Lond). 2006;20(8):908–12.
  5. Chui J, Coroneo MT, Tat LT, Crouch R, Wakefield D, Di Girolamo N. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol. 2011;178(2):817–27.
  6. Dushku N, Reid TW. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res. 1994;13(7):473–81.
  7. Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res. 2004;23(2):195–228.
  8. Tan DT, Lim AS, Goh HS, Smith DR. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol. 1997;123(3):404–5.
  9. Mackenzie FD, Hirst LW, Battistutta D, Green A. Risk analysis in the development of pterygia. Ophthalmology. 1992;99(7):1056–61.
  10. Threlfall TJ, English DR. Sun exposure and pterygium of the eye: a dose-response curve. Am J Ophthalmol. 1999;128(3):280–7.
  11. Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997;115(10):1235–40.
  12. Clearfield E, Muthappan V, Wang X, Kuo IC. Conjunctival autograft for pterygium. Cochrane Database Syst Rev. 2016;2:CD011349.
  13. Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003;48(2):145–80.
  14. Ang LP, Tan DT, Cajucom-Uy H, Beuerman RW. Autologous conjunctival transplantation for recurrent pterygium surgery. Am J Ophthalmol. 2004;138(3):404–9.
  15. Kheirkhah A, Casas V, Sheha H, Raju VK, Tseng SC. Role of conjunctival inflammation in surgical outcome after pterygium surgery with amniotic membrane transplantation. Cornea. 2008;27(1):56–63.
  16. Lam DS, Wong AK, Fan DS, Chew S, Kwok PS, Tso MO. Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology. 1998;105(5):901–4.
  17. Ooi JL, Sharma NS, Sharma S, Dawes JM, Khong CH, Charles PG, et al. Ultraviolet fluorescence photography to detect early sun damage in the anterior segment in a population of surf life savers. Am J Ophthalmol. 2006;141(1):22–30.
  18. Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (review). Int J Mol Med. 2009;23(4):439–47.
  19. Moran DJ, Hollows FC. Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol. 1984;68(5):343–6.
  20. Ang LP, Tan DT. Ocular surface squamous neoplasia. Curr Opin Ophthalmol. 2007;18(4):309–14.

Disclaimer: This guide is for educational purposes and clinical reference. Always exercise professional judgment and follow local regulations and scope of practice guidelines. Refer to ophthalmology when appropriate for complex cases or when outside the optometric scope of practice.